Inventor · disambiguated record
Ethan Shevach
Also filed as: SHEVACH ETHAN · SHEVACH ETHAN M · SHEVACH ETHAN MENAHEM
5 granted patents·4 pending applications·339 citations·filing 2002–2022
79Inventor score
Files withWYETH CORP3THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2THE US SECRETARY DEPARTMENT OF HEALTH1TRAN DAT1US HEALTH1
Top patents by PatentIndex Score
9 records- 0195US7618632B2Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodiesWYETH CORP·Filed 2004·Granted Nov 17, 2009·326 cites·4 claims
- 0285US9481866B2Methods of producing T cell populations enriched for stable regulatory T-cellsUS HEALTH·Filed 2012·Granted Nov 1, 2016·4 cites·15 claims
- 0378US8951793B2Method of making an isolated population of FOXP3+ regulatory T cellsTRAN DAT·Filed 2009·Granted Feb 10, 2015·9 cites·17 claims
- 0474US12195724B2Methods of producing T cell populations enriched for stable regulatory T-cellsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2021·Granted Jan 14, 2025·0 cites·7 claims
- 0564US11060059B2Methods of producing T cell populations enriched for stable regulatory T-cellsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2016·Granted Jul 13, 2021·0 cites·5 claims
- 0657US2010080809A1Gitr ligand and gitr ligand-related molecules and antibodies and uses thereofWYETH CORP·Filed 2009·Application pending·0 cites
- 0755US2008221016A1Cd25+ differential markers and uses thereofWYETH CORP·Filed 2008·Application pending·0 cites
- 0853US2024409640A1Augmentation of innate and adaptive immunity by inhibition of interaction of lilrbs with mhc-1THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2022·Application pending·0 cites
- 0952US2003133936A1CD25markers and uses thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ethan Shevach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →